Neonatal screening for cystic fibrosis:
β
C. FΓ©rec; C. Verlingue; P. Parent; J. F. Morin; J. P. Codet; G. Rault; M. Dagorn
π
Article
π
1995
π
Springer
π
English
β 700 KB
We have evaluated a two-tier neonatal cystic fibrosis (CF) screening of immunoreactive trypsinogen (IRT) followed by CFTR gene mutation analysis using a systematic scanning of exons 7, 10, and 11, and, if necessary, by direct DNA sequencing. Over an 18-month period we screened 32,300 neonates born i